Search clinical trials for: ACT-280778

Total 3045 results

PXL University College
Hasselt University; Ziekenhuis Oost-Limburg; Revalidatie & MS Centrum Overpelt

Completed

Intelligent Activity-based Client-centred Training (i-ACT)

Central Nervous System Diseases | Aged

Belgium
Idorsia Pharmaceuticals Ltd.

Completed

A Clinical Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects

Healthy

Czechia
The Hong Kong Polytechnic University
Hospital Authority, Hong Kong

Completed

Training Parents by Acceptance and Commitment Therapy for Managing Childhood Asthma Care

Childhood Asthma

Hong Kong
West University of Timisoara

Unknown

Online Acceptance and Commitment Therapy for Reducing Anxiety

Anxiety Disorder/Anxiety State

Romania
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA)

Completed

Technology Enhanced Behavioral Activation Treatment for Substance Use

Behavioral Symptoms | Substance-Related Disorders | Depressive Disorder | Sexual Behavior | Risk-Taking

United States
Internistisches Klinikum Munchen Sud

Recruiting

ACT-Measurement at Different Location During Left Atrial Ablation Procedures (ACT)

Atrial Fibrillation

Germany
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects

Healthy Subjects

Germany
Boston Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs (SCRIPT)

HIV Infections | Substance Use | Stigmatization

Russian Federation
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Exercise Values of Life and Vitality Everyday (EVOLVE)

Physical Activity | Exercise | Behavior | Lifestyle | Acceptance and Commitment Therapy | ACT | Lifestyle, Sedentary

United States
National Cancer Institute (NCI)

Completed

Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain

Neurofibromatosis

United States
Drexel University

Completed

Comparing Acceptance and Commitment Therapy (ACT) and Cognitive Therapy (CT) for Test Anxiety

Anxiety

United States
VA Office of Research and Development

Completed

Acceptance-based Group Intervention for Binge Eating

Binge-Eating Disorder

United States
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Moi University; Clinton Health Access Initiative, Nigeria

Completed

Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1 (TESTsmART)

Malaria | Febrile Illness

Kenya
Baylor College of Medicine
US Department of Veterans Affairs

Recruiting

Pelvic Pain Education and Skills Training for Women Veterans

Pelvic Pain | Distress, Emotional

United States
University of Washington

Completed

Integration of Illness Management and Recovery Within ACT (ACT+IMR)

Schizophrenia | Bipolar Disorder | Severe Mental Illness
National Cancer Institute (NCI)

Recruiting

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Neurofibromatosis 1 | Noonan Syndrome | Legius Syndrome | Cardiofaciocutaneous Syndrome | Costello Syndrome

United States
Idorsia Pharmaceuticals Ltd.

Recruiting

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod

Healthy | Hepatic Impairment

Portugal, Hungary
Idorsia Pharmaceuticals Ltd.

Completed

The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics

Healthy | Renal Impairment

Portugal
University Hospital, Montpellier

Completed

Biomarkers of Efficiency of Acceptance and Commitment Therapy in Suicidal Behavior (IMPACT)

Actual Suicidal Behavior Disorder

France
Idorsia Pharmaceuticals Ltd.

Completed

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

Insomnia Disorder

United States, Germany
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Germany
Idorsia Pharmaceuticals Ltd.

Completed

A Study of ACT-541468 in Healthy Japanese and Caucasian Subjects

Healthy Subjects

Netherlands
University of Edinburgh

Completed

An ACT Manual-based, Guided Self-help Intervention Pilot (ACT)

Depression | Anxiety

United Kingdom
Linkoeping University

Completed

Physical Activity and Acceptance and Commitment Therapy as Treatment for Long Term Pain (FACTA)

Chronic Pain

Sweden
Linkoeping University

Completed

Internet-delivered ACT for Treating the Psychological Effects of Hearing Loss

Hearing Loss

Sweden
Midnight Pharma, LLC

Completed

Almorexant in Primary Insomnia (Insomnia)

Insomnia | Primary Insomnia

Austria, Denmark, Finland, Germany, Israel, Netherlands, Spain, Sweden, Switzerland, United Kingdom
Actelion

Completed

Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection

Clostridium Difficile Infection

Croatia
University of Aarhus

Completed

Ready to Act - Health Education in People With Hyperglycaemia

Type 2 Diabetes Mellitus | Behavior

Denmark
Idorsia Pharmaceuticals Ltd.

Completed

A Single Ascending Dose Study of ACT-541468 in Healthy Male Subjects

Healthy Subjects

Netherlands
Idorsia Pharmaceuticals Ltd.

Completed

A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects

Healthy Subjects

United States
Indiana University
Claude McNeal Productions; Lilly Endowment, Inc.

Terminated

Effects of ACT OUT! Social Issue Theater on Youth and Adolescents

Bullying | Social Competence

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Using Novel Behavioral Approaches to Improve Long-Term Weight Loss Outcomes

Obesity

United States
Tel Aviv University

Completed

Attention Control Treatment for Post Traumatic Stress Disorder ׂ(PTSD)

PTSD

Israel
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Healthy

United States
Vanda Pharmaceuticals

Completed

Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment

Hepatic Impairment

United States
Vivantes Netzwerk für Gesundheit GmbH

Recruiting

Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder (ASPIRE)

Psychotic Disorders | Acceptance and Commitment Therapy | Inpatients | Psychotherapy, Group

Germany
Idorsia Pharmaceuticals Ltd.

Completed

Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

Binge-Eating Disorder

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease

Healthy Subjects | Severe Renal Impairment

Czechia
University of Arizona

Completed

Innovative Approach to Reduce Lung Cancer Stigma

Lung Cancer | Stigmatization | Stigma, Social | Acceptance Processes | Lung Cancer Stigma

United States
University Medical Center Goettingen

Completed

Effect of Strategies to Improve General Practitioner-nurse Collaboration and Communication (interprof ACT)

Utilization of Medical Care by Nursing Home Residents

Germany
PXL University College

Completed

Feasibility Study of i-ACT in Aged Persons (i-ACT-aged)

Feasibility of a Technology-based System in Aged Person

Belgium
Utah State University

Completed

Evaluation of the ACT on Health Program

Overweight and Obesity

United States
University Hospital, Montpellier
INSERM 1061, " Neuropsychiatry: epidemiological and clinical research", Montpellier

Withdrawn

DIalectical Behavior Therapy and Acceptance Commitment Therapy Short Program for BOrderLine persOnality Disorder (DIABOLO)

Female | Borderline Personality Disorder

France
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea

Obstructive Sleep Apnea

Germany
Viscogel AB
Karolinska Institutet; Pharma Consulting Group AB

Completed

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine (VSG-2011-101)

Healthy

Sweden
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA)

Completed

Depression Treatment for Low Income Substance Users (LET'S ACT)

Substance Use Disorder

United States
Bristol-Myers Squibb

Completed

Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

Dyslipidemia

Canada, United States, Australia
Idorsia Pharmaceuticals Ltd.

Recruiting

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus (OPUS-1)

Lupus Erythematosus, Systemic

United States, Taiwan, Korea, Republic of, Brazil, France, Poland, Greece, Philippines, Romania, Colombia, Mexico, Bulgaria, Argentina
Tel Aviv University

Completed

ACT With Feedback for Post Traumatic Stress Disorder (PTSD)

PTSD

Israel
University of Amsterdam

Recruiting

Acceptance and Commitment Therapy for Insomnia

Insomnia

Netherlands

Search clinical trials for: ACT-280778

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations